FAM124B
gene geneOn this page
Also known as FLJ22746
Summary
FAM124B (family with sequence similarity 124 member B, HGNC:26224) is a protein-coding gene on chromosome 2q36.2, encoding Protein FAM124B (Q9H5Z6).
Located in mitochondrion and nucleoplasm.
Source: NCBI Gene 79843 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 69 total
- MANE Select transcript:
NM_001122779
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26224 |
| Approved symbol | FAM124B |
| Name | family with sequence similarity 124 member B |
| Location | 2q36.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22746 |
| Ensembl gene | ENSG00000124019 |
| Ensembl biotype | protein_coding |
| OMIM | 618403 |
| Entrez | 79843 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000243806, ENST00000389874, ENST00000409685, ENST00000951903
RefSeq mRNA: 2 — MANE Select: NM_001122779
NM_001122779, NM_024785
CCDS: CCDS2461, CCDS46527
Canonical transcript exons
ENST00000409685 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001941742 | 224401037 | 224402107 |
| ENSE00003515048 | 224378698 | 224380208 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 89.63.
FANTOM5 (CAGE): breadth broad, TPM avg 1.3054 / max 102.5033, expressed in 358 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 34234 | 0.7335 | 278 |
| 34236 | 0.4021 | 128 |
| 34233 | 0.1050 | 38 |
| 34235 | 0.0648 | 28 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.63 | gold quality |
| placenta | UBERON:0001987 | 74.16 | gold quality |
| superficial temporal artery | UBERON:0001614 | 72.52 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 71.14 | gold quality |
| monocyte | CL:0000576 | 69.24 | gold quality |
| mononuclear cell | CL:0000842 | 69.06 | gold quality |
| leukocyte | CL:0000738 | 68.99 | gold quality |
| apex of heart | UBERON:0002098 | 67.90 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 67.52 | gold quality |
| omental fat pad | UBERON:0010414 | 67.49 | gold quality |
| peritoneum | UBERON:0002358 | 67.42 | gold quality |
| adipose tissue | UBERON:0001013 | 67.34 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 66.87 | gold quality |
| connective tissue | UBERON:0002384 | 66.52 | gold quality |
| colonic epithelium | UBERON:0000397 | 66.09 | silver quality |
| lower lobe of lung | UBERON:0008949 | 65.60 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 64.80 | gold quality |
| visceral pleura | UBERON:0002401 | 63.75 | gold quality |
| right lung | UBERON:0002167 | 63.68 | gold quality |
| tibial nerve | UBERON:0001323 | 63.53 | gold quality |
| heart left ventricle | UBERON:0002084 | 63.32 | gold quality |
| upper lobe of lung | UBERON:0008948 | 63.22 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 62.97 | gold quality |
| lower esophagus | UBERON:0013473 | 62.73 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 62.71 | gold quality |
| cardiac ventricle | UBERON:0002082 | 62.68 | gold quality |
| calcaneal tendon | UBERON:0003701 | 62.63 | gold quality |
| gastrocnemius | UBERON:0001388 | 62.48 | gold quality |
| gall bladder | UBERON:0002110 | 62.27 | gold quality |
| muscle of leg | UBERON:0001383 | 62.00 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8271 | yes | 16.44 |
| E-ANND-3 | yes | 5.23 |
| E-MTAB-6678 | no | 2.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
86 targeting FAM124B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-452-5P | 99.65 | 69.63 | 1762 |
| HSA-MIR-4676-3P | 99.65 | 69.31 | 1733 |
| HSA-MIR-892C-3P | 99.65 | 69.38 | 1745 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
Literature-anchored findings (GeneRIF, showing 1)
- Fam124B is a novel protein possibly involved in the pathogenesis of CHARGE syndrome and neurodevelopmental disorders. (PMID:23285124)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam124b | ENSDARG00000087489 |
| mus_musculus | Fam124b | ENSMUSG00000043230 |
| rattus_norvegicus | Fam124b | ENSRNOG00000054416 |
Paralogs (1): FAM124A (ENSG00000150510)
Protein
Protein identifiers
Protein FAM124B — Q9H5Z6 (reviewed: Q9H5Z6)
All UniProt accessions (1): Q9H5Z6
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with CHD7 and CHD8.
Subcellular location. Nucleus.
Similarity. Belongs to the FAM124 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H5Z6-1 | 1 | yes |
| Q9H5Z6-2 | 2 |
RefSeq proteins (2): NP_001116251, NP_079061 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029380 | FAM124 | Family |
| IPR046365 | FAM124_dom | Domain |
Pfam: PF15067
UniProt features (10 total): sequence conflict 3, splice variant 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H5Z6-F1 | 63.74 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 49
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9943962 | CHD6, CHD7, CHD8, CHD9 subfamily |
MSigDB gene sets: 78 (showing top):
GGTGAAG_MIR412, HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP, CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN, IL15_UP.V1_DN, IL2_UP.V1_DN, IL21_UP.V1_DN, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP, LMTK3_TARGET_GENES, TFEB_TARGET_GENES, ZNF592_TARGET_GENES, ZNF766_TARGET_GENES, MIR548AA_MIR548AP_3P_MIR548T_3P, MIR186_5P, MIR497_3P, MIR4778_3P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): nucleoplasm (GO:0005654), mitochondrion (GO:0005739), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| CHD chromatin remodelers | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 2 |
| binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
376 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM124B | CHD8 | Q9HCK8 | 760 |
| FAM124B | CHD7 | Q9P2D1 | 571 |
| FAM124B | FAM174B | Q3ZCQ3 | 518 |
| FAM124B | OR2A2 | Q6IF42 | 478 |
| FAM124B | MANEAL | Q5VSG8 | 448 |
| FAM124B | SPATA13 | Q96N96 | 445 |
| FAM124B | FAM167B | Q9BTA0 | 437 |
| FAM124B | FAM124A | Q86V42 | 432 |
| FAM124B | EBLN2 | Q6P2I7 | 419 |
| FAM124B | ZNF254 | O75437 | 418 |
| FAM124B | RCN2 | Q14257 | 416 |
| FAM124B | SPDYE3 | A6NKU9 | 414 |
| FAM124B | HPDL | Q96IR7 | 407 |
| FAM124B | NAV1 | Q8NEY1 | 404 |
| FAM124B | RPP38 | P78345 | 398 |
IntAct
87 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM124B | MDFI | psi-mi:“MI:0915”(physical association) | 0.710 |
| MDFI | FAM124B | psi-mi:“MI:0915”(physical association) | 0.710 |
| FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRT19 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCF4 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | KRTAP5-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | TLE5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MKRN3 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | KRT31 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| RINT1 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADAMTSL4 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCTD9 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTCH2NLA | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| USHBP1 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| KIAA1958 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | KCTD6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | RBPMS | psi-mi:“MI:0915”(physical association) | 0.560 |
| BIRC7 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM124B | LZTS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM54 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CARD9 | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SSX2IP | FAM124B | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (78): FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), FAM124B (Two-hybrid), USHBP1 (Two-hybrid)
ESM2 similar proteins: A1L3T7, A2AKB4, A2RU30, A5GFW5, A6NP61, A6QLD5, A7E316, B1ASB6, P60924, Q08DK9, Q1XFL1, Q2TAK8, Q2YDQ5, Q3TD16, Q3TYX8, Q3U132, Q3U1D0, Q400C9, Q49AM3, Q571B6, Q5JXC2, Q5JYT7, Q5RA50, Q5SYB0, Q66IK8, Q6DIL6, Q6GQ34, Q6IRU7, Q6P1D7, Q6P1H6, Q6P4T1, Q7TNY7, Q7TSI1, Q7Z572, Q80XI1, Q86V42, Q8BG26, Q8BLQ0, Q8BP86, Q8BVF9
Diamond homologs: A6QLD5, Q5RA50, Q66IK8, Q6DIL6, Q6GQ34, Q86V42, Q8BLQ0, Q9H5Z6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 33 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 6 | 15.9× | 1e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
69 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
227 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:224380209:C:CA | acceptor_loss | 0.9900 |
| 2:224380209:C:CC | acceptor_gain | 0.9900 |
| 2:224401032:AATAC:A | donor_loss | 0.9900 |
| 2:224401033:ATAC:A | donor_loss | 0.9900 |
| 2:224401034:TAC:T | donor_loss | 0.9900 |
| 2:224401035:AC:A | donor_loss | 0.9900 |
| 2:224401036:C:A | donor_loss | 0.9900 |
| 2:224380204:TGAAC:T | acceptor_gain | 0.9800 |
| 2:224380205:GAAC:G | acceptor_gain | 0.9800 |
| 2:224380213:A:T | acceptor_gain | 0.9800 |
| 2:224380207:AC:A | acceptor_gain | 0.9700 |
| 2:224380208:CC:C | acceptor_gain | 0.9700 |
| 2:224380212:C:CT | acceptor_gain | 0.9700 |
| 2:224401063:AGT:A | donor_gain | 0.9600 |
| 2:224380206:AAC:A | acceptor_gain | 0.9500 |
| 2:224401140:TGA:T | donor_gain | 0.9500 |
| 2:224380205:GAACC:G | acceptor_gain | 0.9400 |
| 2:224380207:ACCT:A | acceptor_gain | 0.9400 |
| 2:224401037:C:G | donor_loss | 0.9400 |
| 2:224380206:AACCT:A | acceptor_gain | 0.9200 |
| 2:224380208:CCT:C | acceptor_gain | 0.9200 |
| 2:224380209:C:G | acceptor_gain | 0.9100 |
| 2:224380210:T:A | acceptor_gain | 0.9100 |
| 2:224400424:TGA:T | donor_gain | 0.9100 |
| 2:224401138:CTTGA:C | donor_gain | 0.8800 |
| 2:224401074:TGC:T | donor_gain | 0.8100 |
| 2:224401152:TGCAG:T | donor_gain | 0.8100 |
| 2:224401126:A:AC | donor_gain | 0.8000 |
| 2:224401127:C:CC | donor_gain | 0.8000 |
| 2:224381987:CA:C | donor_gain | 0.7800 |
AlphaMissense
2985 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:224401078:A:G | W231R | 0.996 |
| 2:224401078:A:T | W231R | 0.996 |
| 2:224401149:A:G | F207S | 0.996 |
| 2:224401076:C:A | W231C | 0.995 |
| 2:224401076:C:G | W231C | 0.995 |
| 2:224401393:A:G | W126R | 0.995 |
| 2:224401393:A:T | W126R | 0.995 |
| 2:224401066:C:G | D235H | 0.992 |
| 2:224401088:G:C | S227R | 0.990 |
| 2:224401088:G:T | S227R | 0.990 |
| 2:224401090:T:G | S227R | 0.990 |
| 2:224401644:A:G | F42S | 0.990 |
| 2:224401044:A:G | L242P | 0.989 |
| 2:224401065:T:A | D235V | 0.989 |
| 2:224401077:C:G | W231S | 0.989 |
| 2:224401148:A:C | F207L | 0.989 |
| 2:224401148:A:T | F207L | 0.989 |
| 2:224401150:A:G | F207L | 0.989 |
| 2:224401489:A:G | W94R | 0.989 |
| 2:224401489:A:T | W94R | 0.989 |
| 2:224401064:G:C | D235E | 0.988 |
| 2:224401064:G:T | D235E | 0.988 |
| 2:224401487:C:A | W94C | 0.988 |
| 2:224401487:C:G | W94C | 0.988 |
| 2:224401065:T:G | D235A | 0.987 |
| 2:224401113:A:G | L219P | 0.986 |
| 2:224401305:A:G | L155P | 0.986 |
| 2:224401315:C:G | A152P | 0.986 |
| 2:224401041:A:G | L243P | 0.985 |
| 2:224401728:A:G | L14P | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1000206890 (2:224386226 G>A,T), RS1000364115 (2:224403965 AAC>A), RS1000451886 (2:224397761 T>C), RS1000568038 (2:224398030 T>A), RS1000648527 (2:224387404 C>G), RS1000669880 (2:224393682 G>C), RS1000928779 (2:224380778 C>A), RS1000941498 (2:224387646 C>T), RS1001065849 (2:224393453 G>A), RS1001139021 (2:224402890 C>A,T), RS1001233131 (2:224401341 T>TAC), RS1001504303 (2:224391576 T>G), RS1001556623 (2:224391933 C>T), RS1001836698 (2:224393061 A>G), RS1001951145 (2:224392721 C>A,T)
Disease associations
OMIM: gene MIM:618403 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006088_63 | Familial squamous cell lung carcinoma | 8.000000e-06 |
| GCST008521_11 | Bitter beverage consumption | 2.000000e-06 |
| GCST008524_13 | Bitter non-alcoholic beverage consumption | 5.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006953 | family history of lung cancer |
| EFO:0010089 | bitter beverage consumption measurement |
| EFO:0010093 | bitter non-alcoholic beverage consumption measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| S-(1,2-dichlorovinyl)cysteine | increases expression, affects response to substance | 1 |
| Air Pollutants | affects methylation, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation, decreases methylation | 1 |
| Latex | increases expression | 1 |
| Lipopolysaccharides | decreases expression, affects response to substance, increases expression | 1 |
| Nitrogen Dioxide | affects methylation, increases abundance | 1 |
| Thimerosal | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Asbestos, Serpentine | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | affects methylation, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.